Squarepoint Ops LLC Novartis Ag Put Options Transaction History

Squarepoint Ops LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$106.13 - $120.89 $297,164 - $338,492	2,800 Added 58.33%	7,600 $874,000
Q2 2024 Aug 14, 2024	SELL	$92.57 - $107.37 $472,106 - $547,587	-5,100 Reduced 51.52%	4,800 $511,000
Q1 2024 May 15, 2024	BUY	$95.27 - $108.47 $943,173 - $1.07 Million	9,900 New	9,900 $957,000
Q2 2023 Aug 14, 2023	BUY	$92.52 - $104.91 $4.64 Million - $5.26 Million	50,100 Added 81.6%	111,500 $11.3 Million
Q1 2023 May 15, 2023	BUY	$80.03 - $92.81 $1.65 Million - $1.91 Million	20,600 Added 50.49%	61,400 $5.65 Million
Q4 2022 Feb 14, 2023	BUY	$75.55 - $92.52 $3.08 Million - $3.77 Million	40,800 New	40,800 $3.7 Million

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.